skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

161 studies were found about ( didanosine OR Videx OR Videx EC )

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Condition: HIV; HIV Infections

NCT ID: NCT00358696

A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection

Condition: HIV Infections

NCT ID: NCT00002177

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002168

A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection

Condition: HIV Infections

NCT ID: NCT00002176

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Condition: HIV; HIV Infections

NCT ID: NCT00928187

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00074581

Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy

Condition: HIV Infections

NCT ID: NCT00008866

A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00006208

Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002211

Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients

Condition: HIV Infections; Leukoencephalopathy, Progressive Multifocal

NCT ID: NCT00001048

A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible

Condition: HIV Infections

NCT ID: NCT00000939

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Condition: HIV Infections

NCT ID: NCT00007202

A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV

Condition: HIV Infections

NCT ID: NCT00001049

Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006339

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Condition: HIV Infections

NCT ID: NCT00002429

A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells

Condition: HIV Infections

NCT ID: NCT00000822

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00016718

Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002234

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Condition: HIV Infections

NCT ID: NCT00109590

Bioequivalence Study of Didanosine in Children Treated for HIV

Condition: HIV Infections

NCT ID: NCT00668356

Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

Condition: HIV Infections

NCT ID: NCT00002224

Safety and Effectiveness of a Combination Anti-HIV Drug Treatment

Condition: HIV Infections

NCT ID: NCT00005018

A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Condition: HIV Infections

NCT ID: NCT00001122

A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)

Condition: HIV Infections

NCT ID: NCT00002014

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Condition: HIV Infections

NCT ID: NCT00014937

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006154

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002411

A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine

Condition: Cytomegalovirus Infections; HIV Infections

NCT ID: NCT00002096

Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00008489

Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002240

A Study Comparing Two Forms of Didanosine in HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT00002360

Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00364793

A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals

Condition: HIV Infections

NCT ID: NCT00000772

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00000919

Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00002098

Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00002099

A Study of MKC-442 in Combination With Other Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002412

A Randomized, Placebo-Controlled Study of the Safety and Efficacy of Efavirenz, Didanosine, and Stavudine in Combination With or Without Hydroxyurea in Antiretroviral Naive or Experienced HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002230

A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000839

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00002420

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00002427

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00002418

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001057

A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.

Condition: HIV Infections

NCT ID: NCT00000833

Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease

Condition: HIV Infections

NCT ID: NCT00001045

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Condition: HIV Infection

NCT ID: NCT00026676

A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001022

A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine

Condition: HIV Infections

NCT ID: NCT00000963

A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00000637

A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection

Condition: HIV Infections

NCT ID: NCT00000669

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00116415

A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease

Condition: HIV Infections

NCT ID: NCT00000814

A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3

Condition: HIV Infections

NCT ID: NCT00002123

A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)

Condition: HIV Infections

NCT ID: NCT00000742

A Study of Nystatin in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002313

The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00001035

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Condition: HIV Infections

NCT ID: NCT00013520

A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children

Condition: HIV Infections

NCT ID: NCT00001066

A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past

Condition: HIV Infections

NCT ID: NCT00001029

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Condition: HIV Infections

NCT ID: NCT00000810

Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV

Condition: HIV Infections

NCT ID: NCT00256828

A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)

Condition: HIV Infections

NCT ID: NCT00000781

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

Antiretroviral Therapy for Advanced HIV Disease in South Africa

Condition: HIV

NCT ID: NCT00342355

A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

Condition: HIV Infections

NCT ID: NCT00000916

The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS

Condition: HIV Infections

NCT ID: NCT00001024

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals

Condition: HIV Infections

NCT ID: NCT00001997

A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection

Condition: HIV Infections

NCT ID: NCT00000760

Comparison of ddI Versus Zidovudine in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00000979

A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002207

A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00000652

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00000823

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

Condition: HIV Infections

NCT ID: NCT00000656

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment

Condition: HIV Infections

NCT ID: NCT00000671

A Study of Azidothymidine in HIV-Infected Children

Condition: Encephalopathies; HIV Infections

NCT ID: NCT00000982

A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy

Condition: HIV Infections

NCT ID: NCT00000969

The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001074

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

Condition: HIV Infections

NCT ID: NCT00001063

A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3

Condition: HIV Infections

NCT ID: NCT00000625

Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

Condition: HIV Infections

NCT ID: NCT00002109

The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease

Condition: HIV Infections

NCT ID: NCT00002001

A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)

Condition: HIV Infections

NCT ID: NCT00002028

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Condition: HIV Infections

NCT ID: NCT00102960

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Condition: HIV Infections

NCT ID: NCT00000902

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00006397

Combination Drug Treatment of Pediatric HIV Infection

Condition: HIV Infection

NCT ID: NCT00001818

The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002376

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

Condition: HIV Infections

NCT ID: NCT00000918

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

Condition: HIV Infections

NCT ID: NCT00142337

Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00005000

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Condition: HIV Infections; Hemophilia A

NCT ID: NCT00002386

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00000922

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Condition: HIV Infections

NCT ID: NCT00084136

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00051090

A Study to Compare Two Different Anti-HIV Drug Regimens

Condition: HIV Infections

NCT ID: NCT00000924

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Condition: HIV Infections

NCT ID: NCT00000865

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Condition: HIV Infections

NCT ID: NCT00000838

Study of Anti-HIV Therapy Intensification

Condition: HIV Infections

NCT ID: NCT00034086

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Condition: HIV Infections

NCT ID: NCT00000885

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Condition: HIV Infections

NCT ID: NCT00000891

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

Condition: HIV Infections

NCT ID: NCT00000870

A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002407

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00091936

A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine

Condition: HIV Infections; Leukoencephalopathy, Progressive Multifocal

NCT ID: NCT00002274

A Study of ddI in Children With AIDS Who Have Not Had Success With Zidovudine

Condition: HIV Infections

NCT ID: NCT00002280

Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00000851

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Condition: HIV Infections; AIDS

NCT ID: NCT00122538

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

Condition: HIV Infections

NCT ID: NCT00196612

Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults

Condition: HIV Infections; Antiretroviral Naive

NCT ID: NCT00196599

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001087

A Prospective Cohort of Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00476606

Strategies for Delivering Anti-HIV Therapy in South Africa

Condition: HIV Infections

NCT ID: NCT00080522

A Study of Efavirenz in Combination With Stavudine and Didanosine

Condition: HIV Infections

NCT ID: NCT00002225

Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs

Condition: HIV Infection

NCT ID: NCT00006494

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Condition: HIV Infections

NCT ID: NCT00000923

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

Condition: HIV Infection

NCT ID: NCT00158470

Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

Condition: HIV Infections

NCT ID: NCT00135382

Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment

Condition: Tuberculosis; Human Immunodeficiency Virus Infections

NCT ID: NCT00332306

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Condition: Opioid Dependency; HIV Infections

NCT ID: NCT00877591

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Condition: HIV Infections

NCT ID: NCT00001108

A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine

Condition: HIV Infections

NCT ID: NCT00000770

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00001114

A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy

Condition: HIV Infections

NCT ID: NCT00000803

Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

Condition: HIV Infections

NCT ID: NCT00002035

A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex

Condition: HIV Infections

NCT ID: NCT00000710

The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00000971

A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00000954

A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC

Condition: HIV Infections

NCT ID: NCT00000753

Evaluation of Patients Who Have Not Had Success With Zidovudine

Condition: HIV Infections

NCT ID: NCT00001025

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

Condition: HIV Infections

NCT ID: NCT00618176

Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00000657

An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex

Condition: HIV Infections

NCT ID: NCT00000672

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

Condition: HIV Infections

NCT ID: NCT00000831

Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC

Condition: HIV Infections

NCT ID: NCT00338390

Once Daily 3TC, Efavirenz and ddI for HIV Infection

Condition: HIV Infection; AIDS

NCT ID: NCT00214435

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

Condition: HIV Infections

NCT ID: NCT00002162

The Adult Antiretroviral Treatment and Resistance Study (Tshepo)

Condition: AIDS; HIV Infection

NCT ID: NCT00197613

A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)

Condition: HIV Infections

NCT ID: NCT00002279

A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine

Condition: AIDS-Related Complex; Acquired Immunodeficiency Syndrome

NCT ID: NCT00001267

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

Condition: HIV Infections

NCT ID: NCT00642291

A Study of Saquinavir Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002382

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00005764

A Study of Disease Progression and Anti-HIV Treatments

Condition: HIV Infections

NCT ID: NCT00001068

A Study of WF 10 IV Solution in Patients With Advanced HIV Disease

Condition: HIV Infections

NCT ID: NCT00002152

A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides

Condition: HIV Infections

NCT ID: NCT00002114

Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00000761

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc

Condition: HIV Infections

NCT ID: NCT00703586

The St. Marys and The Mater Switch Study

Condition: HIV Infections

NCT ID: NCT00981773

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

Condition: HIV Infections

NCT ID: NCT00214890

Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals

Condition: HIV Infection; Viremia

NCT ID: NCT00001316

Capravirine to Treat Children With HIV Infection

Condition: HIV Infection

NCT ID: NCT00006519

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00032669

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Condition: HIV

NCT ID: NCT01605084

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex

Condition: HIV Infections

NCT ID: NCT00000976

Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Condition: Lymphoma

NCT ID: NCT00002905

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01363011

Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00707733

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

Condition: AIDS

NCT ID: NCT00207168